← Home / Can-Fite BioPharma Ltd. (CANF)
Stock Analysis
Can-Fite BioPharma Ltd. (CANF)
CANF
CANF · Market data
3.25 -0.91%
Track CANF in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when CANF price is:
52W Range Position
4%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-08-02 19:55 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 3.27. Holding above 3.22 keeps the current thesis intact.
⚖️
✓
Fundamentals
Insufficient / Insufficient
✓
Price Structure
Mixed
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Elevated
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
3.22
↗
Break Above
Confirmation improves above resistance.
3.27
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 3.22
What's Driving CANF?
📈 Technical recovery is improving
Momentum is Neutral. Watch 3.27 for confirmation and 3.22 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 3.22
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
RSI(14)
49.7
Price Chart
CANF — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-31
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$5.4M
Company size
EV
$-1.1M
Debt-adjusted value
P/E
-0.5
Not meaningful
P/S
13.2
Premium
P/B
1.3
Low book multiple
EV/Sales
-2.7
Not meaningful
EV/EBIT
0.1
Low multiple
P/FCF
-0.6
Not meaningful
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial context is mixed
Financial conditions require selective monitoring.
↗
Revenue Growth
Insufficient
●
Profitability
Insufficient
≈
Cash Flow
Insufficient
⚖
Balance Sheet
Strong
💵 Revenue
202,000
≈ Insufficient
📈 Net Income
-4.88M
≈ Insufficient
🧮 EPS (Basic)
0.00
≈ Insufficient
Can-Fite BioPharma Ltd.
Related Opportunities